Publicacións (62) Publicacións de OSCAR JAVIER CORDERO SANTAMARIA

2022

  1. CD26 and Cancer

    Cancers

  2. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

    Cancers, Vol. 14, Núm. 19

  3. Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients

    Archivum Immunologiae et Therapiae Experimentalis, Vol. 70, Núm. 1

2021

  1. Distinctive cd26 expression on cd4 t-cell subsets

    Biomolecules, Vol. 11, Núm. 10

  2. Immunology and immunotherapy in CRC

    Foundations of Colorectal Cancer (Elsevier), pp. 435-453

  3. Population-based universal screening for CRC: Secondary prevention

    Foundations of Colorectal Cancer (Elsevier), pp. 45-56

  4. The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities

    IUBMB Life, Vol. 73, Núm. 5, pp. 761-773

2020

  1. CD26-Related Serum Biomarkers: SCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context

    Disease Markers, Vol. 2020

  2. Immunology and immunotherapy of colorectal cancer

    Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (Springer), pp. 261-289

2019

  1. Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetes

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 33, Núm. 5, pp. 6390-6401

  2. Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26+ cancer stem cells subsets

    Biology Open, Vol. 8, Núm. 7

2018

  1. Oral hygiene might prevent cancer

    Heliyon, Vol. 4, Núm. 10

2017

  1. Activity and expression of dipeptidyl peptidase IV on peripheral blood mononuclear cells in patients with early steroid and disease modifying antirheumatic drugs naïve rheumatoid arthritis

    Clinical Chemistry and Laboratory Medicine, Vol. 55, Núm. 1, pp. 73-81

  2. Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest

    Clinical Biochemistry, Vol. 50, Núm. 16-17, pp. 903-910

  3. Apportioning Blame: Autoreactive CD4+ and CD8+ T Cells in Type 1 Diabetes

    Archivum Immunologiae et Therapiae Experimentalis, Vol. 65, Núm. 4, pp. 275-284

2015

  1. CD26 Expression on T helper populations and sCD26 serum levels in patients with rheumatoid arthritis

    PLoS ONE, Vol. 10, Núm. 7

  2. Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes

    Clinical and Experimental Immunology, Vol. 180, Núm. 2, pp. 207-217

  3. Erratum: CD26 expression on T helper populations and sCD26 serum levels in patients with rheumatoid arthritis (PLoS ONE (2015) 10:7 (e0131992) (DOI:10.1371/journal.pone.0131992))

    PLoS ONE

  4. Immunology and immunotherapy of colorectal cancer

    Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (Springer Berlin Heidelberg), pp. 217-236

  5. Serum dipeptidyl peptidase IV activity and sCD26 concentration in patients with choroidal nevus or uveal melanoma

    Clinica Chimica Acta